Results

1–2 of 2 results for pharmacotherapy

Phase 2 Study of Two Formulations of AR-1105 in Macular Edema (ME) Secondary to Retinal Vein Occlusion (RVO)
Michael A. Singer, MD
Annual Meeting Talks
2021
Impact of Baseline OCT Characteristics on Response to Risuteganib for the Treatment of Intermediate Age-Related Macular Degeneration
Justis P. Ehlers, MD, FASRS
Annual Meeting Talks
2020